FDA Orange Book · active-ingredient family
Diclofenac sodium
Diclofenac sodium is approved as 9 brand and 57 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:DYLOJECT · NDA 022396
9
Brand (NDA)
57
Generics (ANDA)
20
Listed patents
0
Exclusivity periods
Brand (NDA) products · gel, solution, solution/drops, tablet, delayed release, tablet, extended release
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DYLOJECTRLD | JAVELIN PHARMS INC | NDA 022396 | — | Dec 23, 2014 | |
| PENNSAIDRLD | HORIZON | NDA 204623 | — | Jan 16, 2014 | |
| PENNSAIDRLD | NUVO PHARMS INC | NDA 020947 | — | Nov 04, 2009 | |
| VOLTAREN ARTHRITIS PAINRLD | HALEON US HOLDINGS | NDA 022122 | — | Oct 17, 2007 | |
| SOLARAZERLD | FOUGERA PHARMS | NDA 021005 | — | Oct 16, 2000 | |
| VOLTAREN-XRRLD | NOVARTIS | NDA 020254 | — | Mar 08, 1996 | |
| VOLTARENRLD | NOVARTIS | NDA 020037 | — | Mar 28, 1991 | |
| VOLTARENRLD×3 | NOVARTIS | NDA 019201 | — | Jul 28, 1988 | |
| DICLOFENAC SODIUM | FALCON PHARMS | NDA 020809 | — | May 04, 1998 |
Generic (ANDA) products (57)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DICLOFENAC SODIUM×3 | UMEDICA | ANDA 219945 | AB | Nov 05, 2025 | |
| DICLOFENAC SODIUM | ENCUBE | ANDA 217646 | AB | Apr 09, 2025 | |
| DICLOFENAC SODIUM×3 | RUBICON RESEARCH | ANDA 216548 | AB | May 11, 2023 | |
| DICLOFENAC SODIUM | AUROLIFE PHARMA LLC | ANDA 213040 | AB | Feb 03, 2023 | |
| DICLOFENAC SODIUM | ALEMBIC | ANDA 212506 | AB | Nov 29, 2022 | |
| DICLOFENAC SODIUM | SUN PHARMA CANADA | ANDA 208098 | AB | Sep 29, 2022 | |
| DICLOFENAC SODIUM | INGENUS PHARMS LLC | ANDA 216275 | AB | Sep 23, 2022 | |
| DICLOFENAC SODIUM | LUPIN PHARMS | ANDA 208021 | AB | Sep 20, 2022 | |
| DICLOFENAC SODIUM | AMNEAL | ANDA 208198 | AB | Aug 18, 2022 | |
| DICLOFENAC SODIUM | ALEMBIC | ANDA 212351 | BX | Jul 27, 2022 | |
| DICLOFENAC SODIUM | APOTEX | ANDA 207714 | AB | May 06, 2022 | |
| DICLOFENAC SODIUM | EPIC PHARMA LLC | ANDA 206655 | AT | Jan 28, 2021 | |
| DICLOFENAC SODIUM | ENCUBE | ANDA 210986 | — | Jan 27, 2020 | |
| DICLOFENAC SODIUM | RISING | ANDA 208786 | — | Jun 18, 2019 | |
| DICLOFENAC SODIUM | PERRIGO PHARMA INTL | ANDA 211253 | — | May 16, 2019 | |
| DICLOFENAC SODIUM | AUROLIFE PHARMA LLC | ANDA 204306 | — | May 06, 2019 | |
| DICLOFENAC SODIUM | HIKMA | ANDA 209484 | — | Nov 21, 2018 | |
| DICLOFENAC SODIUM | CIPLA | ANDA 209903 | — | Aug 03, 2018 | |
| DICLOFENAC SODIUM | PADAGIS ISRAEL | ANDA 210893 | AB | Jul 27, 2018 | |
| DICLOFENAC SODIUM | ZYDUS LIFESCIENCES | ANDA 206411 | AT | Apr 17, 2018 | |
| DICLOFENAC SODIUM | RISING | ANDA 206715 | — | Aug 07, 2017 | |
| DICLOFENAC SODIUM | GLENMARK PHARMS LTD | ANDA 208301 | AB | Sep 13, 2016 | |
| DICLOFENAC SODIUM | AMNEAL PHARMS | ANDA 206116 | AT | Sep 02, 2016 | |
| DICLOFENAC SODIUM | SUN PHARMA CANADA | ANDA 206298 | AB | Apr 28, 2016 | |
| DICLOFENAC SODIUM | AMNEAL PHARMS | ANDA 208077 | — | Mar 18, 2016 | |
| DICLOFENAC SODIUM | NOVEL LABS INC | ANDA 205878 | AT | Dec 09, 2015 | |
| DICLOFENAC SODIUM | ACTAVIS MID ATLANTIC | ANDA 206493 | AB | Dec 02, 2015 | |
| DICLOFENAC SODIUM | ALTAIRE PHARMS INC | ANDA 203383 | AT | Nov 16, 2015 | |
| DICLOFENAC SODIUM | LUPIN | ANDA 204132 | AT | Aug 20, 2015 | |
| DICLOFENAC SODIUM | PAI HOLDINGS PHARM | ANDA 202769 | — | Jul 08, 2015 | |
| DICLOFENAC SODIUM | SUN PHARMA CANADA | ANDA 203818 | AT | Nov 26, 2014 | |
| DICLOFENAC SODIUM | TWI PHARMS | ANDA 202393 | — | Nov 24, 2014 | |
| DICLOFENAC SODIUM | WATSON LABS INC | ANDA 202852 | AT | Nov 24, 2014 | |
| DICLOFENAC SODIUM | APOTEX | ANDA 202027 | — | May 27, 2014 | |
| DICLOFENAC SODIUM | AMNEAL | ANDA 200936 | — | Oct 28, 2013 | |
| DICLOFENAC SODIUM×2 | UNIQUE | ANDA 090066 | AB | Dec 01, 2010 | |
| DICLOFENAC SODIUM | RUBICON RESEARCH | ANDA 077600 | AT | Nov 13, 2008 | |
| DICLOFENAC SODIUM | SCIEGEN PHARMS | ANDA 077845 | — | Apr 17, 2008 | |
| DICLOFENAC SODIUM | SANDOZ | ANDA 078031 | AT | Feb 06, 2008 | |
| DICLOFENAC SODIUM | BAUSCH AND LOMB | ANDA 078792 | AT | Dec 28, 2007 | |
| DICLOFENAC SODIUM | RISING | ANDA 078553 | AT | Dec 28, 2007 | |
| DICLOFENAC SODIUM | UNIQUE | ANDA 077863 | AB | Jun 08, 2007 | |
| DICLOFENAC SODIUM | DEXCEL LTD | ANDA 076201 | AB | Nov 06, 2002 | |
| DICLOFENAC SODIUM×2 | AUROBINDO PHARMA USA | ANDA 075281 | AB | Feb 12, 2002 | |
| DICLOFENAC SODIUM | ACTAVIS ELIZABETH | ANDA 075910 | — | Jan 07, 2002 | |
| DICLOFENAC SODIUM | AUROBINDO PHARMA USA | ANDA 076152 | — | Dec 13, 2001 | |
| DICLOFENAC SODIUM | VPNA | ANDA 075492 | AB | Feb 11, 2000 | |
| DICLOFENAC SODIUM×2 | PLIVA | ANDA 074432 | — | Jul 29, 1999 | |
| DICLOFENAC SODIUM | TEVA | ANDA 074723 | — | Mar 30, 1999 | |
| DICLOFENAC SODIUM×2 | MICRO LABS | ANDA 074986 | — | Feb 26, 1999 | |
| DICLOFENAC SODIUM×3 | CARLSBAD | ANDA 075185 | AB | Nov 13, 1998 | |
| DICLOFENAC SODIUM×3 | TEVA PHARMS | ANDA 074459 | — | Jun 25, 1997 | |
| DICLOFENAC SODIUM | TEVA | ANDA 074390 | — | Aug 15, 1996 | |
| DICLOFENAC SODIUM×2 | ACTAVIS ELIZABETH | ANDA 074514 | AB | Mar 26, 1996 | |
| DICLOFENAC SODIUM | CHARTWELL RX | ANDA 074394 | — | Nov 30, 1995 | |
| DICLOFENAC SODIUM×2 | CHARTWELL RX | ANDA 074376 | — | Sep 28, 1995 | |
| DICLOFENAC SODIUM×3 | ROXANE | ANDA 074391 | — | Jun 29, 1995 |
Listed patents (20)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8946292 | Mar 22, 2027 | in 9 mo | U-1659 |
| 9132110 | Oct 17, 2027 | in 1 yr 4 mo | U-1488 |
| 9168305 | Oct 17, 2027 | in 1 yr 4 mo | U-1488 |
| 9066913 | Oct 17, 2027 | in 1 yr 4 mo | ProductU-1488 |
| 9339551 | Oct 17, 2027 | in 1 yr 4 mo | U-1488 |
| 9220784 | Oct 17, 2027 | in 1 yr 4 mo | U-1488 |
| 9339552 | Oct 17, 2027 | in 1 yr 4 mo | ProductU-1488 |
| 9539335 | Oct 17, 2027 | in 1 yr 4 mo | U-1614 |
| 8563613 | Oct 17, 2027 | in 1 yr 4 mo | ProductU-1488 |
| 8871809 | Oct 17, 2027 | in 1 yr 4 mo | U-1614 |
| 9101591 | Oct 17, 2027 | in 1 yr 4 mo | ProductU-1488 |
| 9168304 | Oct 17, 2027 | in 1 yr 4 mo | Product |
| 8252838 | Apr 21, 2028 | in 1 yr 10 mo | ProductU-1489 |
| 8741956 | Jul 10, 2029 | in 3 yr 1 mo | U-1435 |
| 8618164 | Jul 10, 2029 | in 3 yr 1 mo | U-1477 |
| 9370501 | Jul 10, 2029 | in 3 yr 1 mo | U-1614 |
| 8217078 | Jul 10, 2029 | in 3 yr 1 mo | U-1477 |
| 9375412 | Jul 10, 2029 | in 3 yr 1 mo | U-1614 |
| 9415029 | Jul 10, 2029 | in 3 yr 1 mo | U-1614 |
| 8546450 | Aug 09, 2030 | in 4 yr 2 mo | U-1435 |
Diclofenac sodium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

